Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

NCT01467700 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
490
Enrollment
INDUSTRY
Sponsor class

Stopped Business Decision; No Safety Concerns

Conditions

Interventions

Sponsor

Takeda